Level Four Advisory Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

Level Four Advisory Services’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$264K	Sell	2,418 -174	-7%	-$18K	0.01%	812
2026 Q1	$269K	Sell	2,592 -12,328	-83%	-$1.31M	0.01%	753
2025 Q4	$1.54M	Sell	14,920 -111	-0.7%	-$10.8K	0.05%	330
2025 Q3	$1.36M	Sell	15,031 -22,464	-60%	-$1.97M	0.05%	342
2025 Q2	$3.3M	Buy	37,495 +1,132	+3%	+$98.1K	0.12%	207
2025 Q1	$3.31M	Buy	36,363 +4,346	+14%	+$391K	0.14%	190
2024 Q4	$2.76M	Buy	32,017 +1,157	+4%	+$105K	0.11%	205
2024 Q3	$2.82M	Sell	30,860 -8,778	-22%	-$834K	0.12%	196
2024 Q2	$3.63M	Buy	+39,638	New	+$3.54M	0.16%	174

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Level Four Advisory Services's PPH Position: Q2 2026 in Review

Level Four Advisory Services reduced its VanEck Pharmaceutical ETF (PPH) stake by 6.7% in Q2 2026, selling an estimated $18K and leaving 2,418 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #812.

Level Four Advisory Services first reported a position in PPH in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.63M in Q2 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Level Four Advisory Services held 2,418 shares of VanEck Pharmaceutical ETF worth $264K as of Q2 2026.
Level Four Advisory Services sold 174 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $18K.
VanEck Pharmaceutical ETF made up 0.01% of Level Four Advisory Services's portfolio in Q2 2026, its #812 holding.
Level Four Advisory Services first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and has held it in 9 quarters since.
Level Four Advisory Services's VanEck Pharmaceutical ETF position peaked at $3.63M in Q2 2024.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.